RHOSHAN PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Apr 2026)
What this means for you
Registered since 24 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88115688
- Registration number
- 5945415
- Mark type
- Stylized text
- Filed
- 13 Sept 2018
- Published for opposition
- 26 Mar 2019
- Registered
- 24 Dec 2019
- Attorney of record
- Michael N. Mercanti
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and drug development services; Clinical research and testing services in the fields of pharmaceuticals; Scientific research and development services; Drug discovery services
Owner
- Rho Pharmaceuticals, LLC, Southampton, PA, US
- Rho Pharmaceuticals, LLC, Southampton, PA, US
- Rho Pharmaceuticals, LLC, Southampton, PA, US
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Apr 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 02 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Nov 2019 — USE AMENDMENT FILED
- 14 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Nov 2019 — TEAS STATEMENT OF USE RECEIVED